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As soon as they enter a biological medium (cell culture medium for in vitro, blood or
plasma for in vivo studies), nanoparticles, in most cases, see their surface covered by
biomolecules, especially proteins. What the cells see is thus not the ideal nanoparticle
concocted by chemists, meaning the biomolecular corona could have great biological
and physiological repercussions, sometimes masking the expected effects of purposely
grafted molecules. In this review, we will mainly focus on gold nanoparticles. In the first
part, we will discuss the fate of these particles once in a biological medium, especially
in terms of size, and the protein composition of the corona. We will highlight the
parameters influencing the quantity and the identity of the adsorbed proteins. In a
second part, we will resume the main findings about the influence of a biomolecular
corona on cellular uptake, toxicity, biodistribution and targeting ability. To be noticed is
the need for standardized experiments and very precise reports of the protocols and
methods used in the experimental sections to extract informative data. Given the
biological consequences of this corona, we suggest that it should be taken into
account in theoretical studies dealing with nanomaterials to better represent the
biological environment.
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Since the beginning of the twentieth century [1], manufactured gold nanoparticles
(GNP) have been constantly developed for biomedical applications, be it for diagnosis
or therapy [2-5]. The enthusiasm aroused by their unique properties, among which
spectroscopic and catalytic, and the possible progress they could generate, lead some
to talk about a new “Golden Age” [4]. With years, the design of nanoparticles (NP) is
complexifying, allowing multiple functionalities on the same object [6-8]. Such sophis-
tication is not achievable with small organic molecules or metallic salts, which ac-
counts for the impetus to consider NP as theragnostic platforms. However, once in a
biological environment, NP are submitted to new interactions and constraints that
could affect their performance (enzymatic digestion, mechanical stress due to rapid
blood flow, corrosion, ligand exchange…). In particular, NP are expected to interact
with biomolecules, such as proteins, lipids, nucleic acids and even metabolites, in large
extent because of their large surface-to-mass ratio. In fact, the awareness that the syn-
thetic identity of NP could greatly differ from their biological identity is now spreading.2014 Brun and Sicard-Roselli; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly credited.
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highly sensitive analytical techniques, there has been a growing number of papers deal-
ing with the formation of a protein corona at the surface of NP [9-12]. Usually, one dis-
tinguishes two components in this dynamic process: the soft and the hard coronas. Soft
and hard coronas can be defined by their relative affinity for NP surface and exchange
times. Hard corona is made by a protein fraction strongly bound to the surface while
soft corona is formed by loosely-bound proteins, maybe via protein-protein interaction
[10]. The protein corona can thus be multi-layered. NP surface may then get modified
and the corona may substantially influence the biological response.
In this review, we will focus mainly on gold nanoparticles (GNP). In a first part, cor-
ona characterization will be summarized. We will attempt to draw the main findings
regarding what happens to GNP in a biological fluid in terms of size, charge, aggrega-
tion state and corona composition. In a second part, we will wonder how this biomo-
lecular corona influences cellular uptake, toxicity, biodistribution and targeting ability.Review
GNP size is expanded by biomolecular corona
In the attempt to determine metallic NP size, a wide variety of techniques are now
available allowing fine characterization [13]. The most commonly encountered are
transmission electron microscopy (TEM), absorption UV-Visible spectroscopy to probe
plasmon resonance (PR) and dynamic light scattering (DLS). Differential centrifugal
sedimentation (DCS) and, more recently, nanoparticle tracking analysis (NTA) were
also developed to determine NP hydrodynamic parameters. Figure 1 presents some of
the results one can obtain from such techniques. TEM can be considered as the most
direct method to visualize NP and determine metallic core shape and dimensions. For
reliable results, it necessitates a manual measurement of objects, considered sufficient
for a few hundreds of particles [14,15] (Figure 1, left upper part). In addition to core,
coloration treatments, with uranyl acetate for example [16], could allow coating
visualization and thickness estimation (Figure 1, left bottom part). Specific to metallic
NP, plasmon resonance (PR), which is the collective oscillation of electrons at the me-
tallic surface, also gives access to size information [17,18]. GNP plasmon resonance is
located in the visible region at ca. 530 nm and for citrate-capped GNP, the wavelength
of PR varies linearly with diameters from 10 to 70 nm and with a steeper dependence
beyond [19-22] (Figure 1, right upper part). This easy-to-use spectroscopy then appears
as very powerful and therefore essential for NP size control. Resonance plasmon wave-
length is also sensitive to ligand grafting or NP aggregation. Nevertheless, no precise
characteristic about the coating can be extracted from such a parameter. On the con-
trary, DLS [23,24] and NTA [25,26] rely on brownian movements of nanoparticles. Fur-
thermore, DCS [27-29] offers measurements of NP size including both their core and
shell according to sedimentation through a density gradient, that allows computing of
diameter details linked to the ligand shell in the case of monolayer protected clusters
and other particles. Hydrodynamic diameter is defined as the NP diameter imple-
mented with a diffuse layer made of solvent molecules and ions present in solution and
with grafted molecules when functionalization was performed (Figure 1, central part).
One advantage of DLS is that, contrary to TEM, it allows the analysis of a high number
Figure 1 Schematic illustration of some techniques allowing the determination of NP size. Such
techniques can be classified into two categories, those giving access to the size of the metallic core and
those providing NP hydrodynamic diameters. Central part: Scheme of a functionalized NP with the water
molecules of its solvation layer. Upper part: TEM and UV–vis spectroscopy allows the determination of the
core size. TEM necessitates the measurement of a sufficiently high number of objects to obtain a meaningful
distribution as the one presented. Correlation between PR position and NP diameters can be extracted from
literature and so UV–vis spectroscopy can give an estimation of NP size in a routine control procedure. Some
data were extracted from supplier websites (Sigma-Aldrich and Nanopartz). Lower part: TEM, with an extrinsic
coloration, allows the visualization of the biomolecular corona and the measurement of its thickness. DLS and
NTA utilize the properties of Brownian motion to provide hydrodynamic diameters. However, the average and
distribution given by DLS is weighted by particule size whereas NTA is a particle by particle analysis.
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analysis leads to an average and accurate size distribution if experimental conditions
are carefully optimized [24,30,31]. DLS is more documented for protein corona ana-
lysis, especially for GNP, though care should be taken about large particle contribution
because the scattered light intensity varies as D6 (D = NP diameter), which is not the
case for NTA which analyses each particle individually (Figure 1, bottom part). As DLS
can provide results in intensity, volume and number, attention should be paid as the
raw data are expressed in intensity and do not represent the relative proportions of
small and large particles in the sample. To be noticed, some claims that only the hard
corona is probed by DLS measurements [32]. As for DCS, one of its advantages is the
sensitivity of this method to small surfaces changes [27]. Combination of these tech-
niques then leads to a precise corona thickness depiction.
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when GNP are dispersed in biological fluids, DLS shows an increase of their hydro-
dynamic size. As mentioned in several references of Table 1, based on DLS only, ag-
glomeration cannot be excluded. To get information on this point, several authors
performed UV-visible spectroscopy and plasmon resonance generally confirms that, in
the presence of fetal calf serum (FCS), size increases are the result of protein adsorp-
tion: PR shifts due to a change of refractive index. DCS can also give valuable informa-
tion on aggregation patterns, however it is less used until now. On the contrary,
physiological conditions in the absence of FCS seem to induce predominantly agglom-
eration [33]. Corona formation is expected to depend on several parameters such as
size, charge and coating of GNP. For non-coated GNP, according to Maiorano [34],
citrate-GNP size determined by DLS in DMEM supplemented with FCS is about
200 nm whatever their original size is (Table 1). This is not in agreement with Wang
who showed that 20 nm citrate- NP diameter increases from 20 to 83 nm in DMEM



























citrate 15 40 200 [34]
40 70 200 [34]
80 150 200 [34]
−21* 20 83 [35]
−38 30 33 25 76 30 min [40]
−34 50 55 25 100 30 min [40]
−33 4 5.3 6.1 48 h [36]
−44 10 10.1 16.4 48 h [36]
−42 13 13.1 22.3 48 h [36]
−43 24 24.2 44.7 48 h [36]
−45 40 40.6 59.6 48 h [36]
NH3
+ 64 10 12 40.7 48 h [36]
COO− 10 24 108 [33]
25 41 95 [33]
50 65 88 [33]
100 97 110 [33]
−56 10 12 11.8 48 h [36]
TPPBS −35 5 11 25 63.2 [32]
−32 15 19 25 75.6 [32]
−43 80 88.3 25 122.3 [32]
peptide −18* 20 45 [35]
When available, characteristics of nanoparticles are indicated (zeta potential, core diameter, hydrodynamic diameter in
water) as well as the media composition and the incubation time. As underlined in the text, most studies do not give
details about their DLS measurement conditions.
* = 10%FBS.
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is influenced by the presence of a specific charge and/or coating. In DMEM with
serum, COOH-coated objects which exhibit additional negative charge from the carb-
oxylate groups at physiological pH swell up to ca. 100 nm whatever their original size
[33]. A similar tendency was evidenced by Casals et al. but with a lower final size [36].
NP-TTPPBS (bis-sulfonatetriphenylphosphine) in DMEM exhibit a large increase for
small objects (<20 nm) and a weaker one for 88 nm NP [32]. It seems anyhow that the
smaller GNP, the higher diameter rise. Moreover, the type of medium induces a differ-
ent behavior as shown by Maiorano comparing DMEM and RPMI for which final sizes
and protein adsorption kinetics prove to be different [34].
These examples highlight the absence of any consensus concerning the extent of
GNP size increase by the biomolecular corona. Indeed, it should be noticed that in
Wang et al., DLS measurements were performed after centrifugation and resuspension
of the sample in a buffer, preparation that could remove a high quantity of loosely
bound proteins. DLS temperature measurements should also be considered as it can
modify protein/NP association [37]. These particularities illustrate the fact that experi-
mental conditions are decisive. Comparison of different assays can be hazardous when
DLS measurements are not performed under identical conditions. Pitfalls could then
arise from diversified NP time of incubation in the medium and with cells, temperature
of DLS analysis, order of component mixing (serum/medium/NP), …. Then a fine read-
ing and comparison of experimental conditions appear necessary to extract any ten-
dency of NP behavior in physiological medium.Corona composition: proteins identification and quantification
Functionalization appears here as a decisive parameter for the quantity and identity of
proteins implicated in NP corona. As polyethyleneglycol (PEG) is the most frequently
grafted polymer on NP to reduce opsonization, it has been most studied. First, it has
been clearly demonstrated by Walkey et al. that for a constant GNP size, PEG grafting
increase leads to a total protein adsorption decrease [38]. Indeed, weak PEG density
was shown to reduce the thermodynamic barrier to protein adsorption. In the case of a
constant ligand grafting, the size of the NP seems crucial as its lowering enhances total
protein adsorption. This was also demonstrated in ref [32]. Dobrovolskaia also showed
that increasing PEG molecular weight grafted on GNP diminishes the total amount of
adsorbed proteins [39].
To identify proteins in the corona, two main approaches are commonly used: 1D and
2D SDS-PAGE and mass spectrometry. Nevertheless, here also sample preparation and
conditioning can perturb the protein corona. As a consequence, mainly hard corona is
analyzed showing anyhow more than nearly one hundred different proteins [40-42].
Electrophoresis, a routine technique, has allowed evidencing the quantity of total pro-
teins and their mass repartition in most studies so far. To be noticed is also the devel-
opment of micro-BCA or Bradford assay as a tool for relative protein quantification in
samples but far fewer papers refer to this technique [43]. NP charge and hydrophobicity
appear crucial for the identity of proteins bound to NP as electrostatic interactions are
often responsible for the hard corona formation. Unsurprisingly, Casals et al. evidenced
negatively-charged serum proteins adsorbed on positively-charged GNP [36]. Moreover,
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respectively 15% and 2% of total for GNP which diameters are <10 nm and equal to
80 nm [32]. Coating density is also a key parameter: Walkey et al. identified 147 pro-
teins at the surface of pegylated NP and correlated a high PEG density with a smaller
range of protein size present [38]. More precisely, 50 to 80 kDa proteins were more
abundant on highly-grafted pegylated NP. In addition, Dobrovolskaia showed that NP
pegylation doesn’t change the type of plasma protein composition of the corona though
it changes the total amount of proteins [39].
Protein identification has benefited from proteomic approaches and increased sensi-
tivity of apparatus. First, it is to be noticed that the composition of the corona is not
the reflect of the surrounding medium, which seems to be independent of the NP type
[34,42,44]. By mass spectrometry, the major proteins identified in the corona of GNP
in complete cell culture medium are albumin, immunoglobulin and fibrinogen or gly-
coproteins as can be expected from the presence of FCS [33,34,36]. In addition, com-
plement factor C3 was shown to be predominant for ungrafted NP representing ca.
30% (w/w) of total proteins or 5% for a high density PEG functionalization [32,38].
Dobrovolskaia also detected this complement protein on citrate-coated NP without any
induction of activation. It is also important to notice the presence of fibrinogen but
without any platelet activation [32,40]. A meaningful example of LC-MS/MS analysis
performance is the study of Sisco et al., where distinction between bovine proteins
from serum and proteins produced by the rat fibroblasts was achieved, pointing out a
possible biological role of rat biglycan protein sequestration in the corona of NR [45].
Albanese et al. also profited by the analytical power of mass spectrometry to show that
cell-secreted proteins progressively replace serum proteins in the protein corona
around citrate-coated GNP in a time- and phenotype-dependent manner, underlying
protein corona is a dynamic process [46].
Some studies carefully depicted corona composition with more than one hundred
proteins identified. Nevertheless it is utopic to believe that complete corona analysis is
accomplished. Given the huge number of different proteins in corona, only part of
them is identified. It cannot be excluded that some proteins present at a minor level
and so not cited in the literature could be responsible for the major biological conse-
quences discussed below. Considering the variety of nanomaterials in nature, size,
shape and coating as long as the different sources of proteins and cell lines, it is diffi-
cult to draw absolute conclusions. Still, we believe some trends to be trustworthy. We
will uppermost examine studies with GNP but given the paucity of data, we will some-
times refer to other NP.The presence of the corona reduces non-specific cellular uptake
A first question of interest is: does the biomolecular corona increase NP uptake by cells?
At this point we must distinguish non-specific from specific uptake. Specific internaliza-
tion is regulated by membrane receptors that are only activated by receptor-specific li-
gands to trigger internalization. Non-specific uptake is a random process without specific
biomolecular control by the cell. We will discuss first the non-specific process.
When studying the impact of serum proteins on cellular uptake, it seems clear that
the extent of NP internalization depends greatly on the presence of a corona.
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nitude higher uptake without serum for two different peptide-coated GNP [35]. For
oligonucleotide-functionalized GNP, Patel et al. reported a 150% increase in uptake in
serum-free medium [47]. Similarly, the uptake of FePt NP or quantum dots (QDs) by HeLa
cells were greatly reduced by the formation of a corona compared to the bare NP [48,49].
This trend was also reported for A549 cells with silica NP [50] or with carboxylated poly-
styrene NP, with the highest uptake occurring in serum-free MEM [51], for human macro-
phages with a 4-fold uptake of polystyrene NP in HBSS than in 10% human serum RPMI
[52], and for mouse macrophages [53]. Once covered with similar biomolecular corona, it
seems that same-shaped NP behave the same whatever their core composition. More pre-
cisely, the total amount of proteins in the corona seems to impact the extent of uptake. For
example, GNP of 15, 40 and 80 nm showed all a different behavior in DMEM and RPMI
media supplemented with 10% FBS, with a more abundant corona formed in DMEM. Even
though HeLa cells exhibit the same growth rate in the two media, a lower uptake of NP
was reported in DMEM [34]. More intriguing, serum heat inactivation also seems to influ-
ence NP uptake, even for A549 cells that are known to be insensitive to the complement: a
correlation was found between more proteins in the hard corona in the case of heat-
inactivated serum and a lower uptake [54]. The reason evoked is the reduction of particles
cell membrane adhesion when a biomolecular corona is formed [51,55].
Interestingly, a few studies reported that the biomolecular corona could promote specific
uptake: for a couple (NP, cell line) showing the folate-receptor involvement, selective uptake
was annihilated without serum [56]. In a differentiated macrophage-like cell line (dTHP1),
surexpressing the class A scavenger receptor (SR-A) in charge of the recognition of modi-
fied proteins and lipoproteins for their subsequent clearance, Yan et al. did not observe any
change in effective association and internalization with the presence of serum [55]. But they
suggested that the SR-A mediated phagocytosis is only active in the presence of the corona
through the recognition of unfolded BSA at the surface of the NP. Prapainop et al. also ad-
dressed the question of a relationship between misfolded proteins in the corona and cellular
uptake by macrophages: they grafted an inflammatory metabolite (cholesterol 5,6-secosterol
atheronal B) known to affect protein folding on QDs, and reported a measurable QD uptake
for concentration of 10 nM whereas atheronal-free QDs were not taken up by cells even at
100 nM [57]. As for Caracciolo et al., they suggested that NP, through the formation of a
protein corona, could target specific cells if among the main coating proteins resides one,
still functional, which receptor is overexpressed in diseased cells [58].
So non-specific uptake seems to be decreased in the presence of a corona whereas specific
uptake seems to be promoted, sometimes at least, by the protein corona, because a misfold-
ing of corona proteins trigger NP uptake by specific cells that otherwise would not have
done so or because there is a protein in the corona able to target a specific receptor
expressed in the cell line used. All these results highlight how important each cell line speci-
ficity is. Beyond the evident biological relevance of these new findings, they could also allow
the reconsideration of a whole part of literature as regards inconsistencies in NP uptake
studies as incubation conditions, and especially serum presence, seem to play a major role.
The presence of the corona generally reduces NP toxicity
As a consequence of a lower uptake, the presence of the corona induces a lower tox-
icity of nanomaterials. This was, for example, emphasized by a complete set of toxicity
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servables were quantified: mitochondrial activity through WST-8 assay, membrane in-
tegrity with LDH release measurement, apoptosis by flow cytometry and DNA
fragmentation with Tunel test. Possible interferences between GNP and the different
assays were verified, allowing to state with certainty that the smaller corona GNP in-
duce the higher uptake and the higher toxicity. This has also been reported for carbon
nanotubes [59], graphene oxide nanosheets [60] or biopolymeric NP in several cell lines
[53]. In the case of well-known toxic nanomaterials such as CTAB-coated gold nano-
rods (NR) or positively-charged polystyrene NP, the biomolecular corona also plays a
protective role as regards membrane damage [61,62]. With FBS-coated CTAB NR,
within a 24 h time frame, no morphological impairment of the membrane such as blebs
or loss of microvilli was observed, suggesting the corona prevents the amphiphilic
CTAB from interacting with the phospholipid bilayer. Interestingly, it has been shown
recently that the corona remains bound during internalization and trafficking inside
the cell [61-63]. This means that the protective effect of the corona could last as long
as it is intact and effectively, a delayed toxicity was observed in the previous cited stud-
ies, corresponding to the degradation of the corona inside the lysosomes and the re-
exposition of the toxic surface [61-63]. Nevertheless, to the best of our knowledge, such
study does not exist yet for GNP.
However, toxicity could be triggered, related to endogenous proteins modifications at
the NP surface. This could imply a modulation of biological activity, as observed for ca-
thepsins B and L in the presence of GNP [64] possibly leading to an impairment of the
cell machinery, a recognition of immunoglobulins or unfolded protein leading to
macrophage activation [55,65] and inflammation [66].
It has also been suggested to take advantage of the protein corona to load small mo-
lecular therapeutics such as DNA or doxorubicin [67,68] to induce a toxicity to cancer-
ous cells. Corona seems to act as sponge with a higher payload capacity than what is
observed with covalent conjugation strategies. Passive release can be tuned by varying
the corona composition and a triggered drug release can be achieved by laser excitation
at the longitudinal PR of the gold NR. This pioneering work underlines that, as corona
formation is unavoidable, a strategy is needed to exploit it.The presence of the corona influences biodistribution
If the influence of NP PEGylation on biodistribution is known for years [69-72], the
thorough characterization and consequences of a biomolecular corona formed in vivo
has not been investigated yet. However, of interest are several studies dealing with a
pre-coating of the NP with proteins, namely with serum albumin and apolipoprotein E
[53,73,74]. Whatever the nature of the NP core, polymeric or metallic, it seems that
such a pre-coating increases the blood circulation time and reduces the clearance
speed. For example, a 6-fold increase of half-time was reported by Peng for BSA-pre-
coated NP compared to “bare” NP [53]. Based upon in vitro experiments, the authors
proposed as an explanation a weakened opsonization and a reduced phagocytosis. In all
these studies, liver stays the main organ of NP accumulation (more than 90% of the
injected dose after 19 h [74]). Still, the protein used for pre-coating seems to nuance
the amounts of NP in other organs, albumin targeting lungs preferentially, and brain to
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tention when pre-coating NP with albumin in cancer therapy as specific factors account
for the accumulation of this protein in solid tumors: a decreased level of HSA in cancer
patients, inducing a need for albumin digestion to cover the need in amino acids for
tumor growth and the presence of two albumin receptors, gp60 in tumor endothelium
and SPARC in tumor interstitium [75].The presence of the corona impacts targeting ability
When it comes to therapeutic applications, one main advantage of NP is the multifunc-
tional platform they can become: to address them to diseased cells, functionalization of
their surfaces with antibodies, aptamers or other biomolecules is usually involved.
Using a click chemistry reaction between azide-functionalized surfaces and bicyclononyne-
silica NP (BCN-NP) as a model of targeting, Mirshafiee and coll quantified the targeting ef-
ficiencies of such NP in the presence of 10 or 100% FBS : they were lowered by 94 and 99%
respectively compared to bare BCN-NP [76]. Such a loss of recognition between the ligand
and its target was also depicted in cellular experiments. Constructing gold nanoconjugates
with a KDEL-labelled peptide, meant to activate a specific transport pathway, and with a
random sequence peptide as a control, Wang et al. concluded that, in the presence of
serum, non-specific mechanisms of uptake were more robust [35]. Similar results were ob-
tained in the study of transferrin (Tf)-functionalized silica NP [77]: with increasing serum
concentration, the targeting capacity of Tf-NP was lost, even when a secondary PEG layer
was added to control unspecific protein binding. These observations emphasize that the
grafting of a functional ligand is not enough to guarantee the recognition by the corre-
sponding receptor. The biomolecular corona seems to act as a “screen”, preventing NP to
discriminate the “right” cells. More recently, Dai et al. showed that choosing the correct
length of PEG chains could allow to re-establish a selective targeting in the presence of
serum [78], suggesting strategies to overcome this difficulty.Conclusions
In this review, we wondered what happens to GNP once in cell culture medium. In the
presence of serum, what the cell sees is a larger object, the smaller particles being more
affected. NP charge can also be modified. Quantity and identity of proteins in the cor-
ona are affected by NP size and charge but also by functionalization. In any case, the
composition of the corona is not the exact reflect of the composition of the biological
fluid: there is a selection process. Extracting general conclusions was awkward as exam-
ining this limited body of literature evidences the high importance of carrying standard-
ized experiments, knowing techniques limitations and writing well-documented
experimental sections to enable cross-comparisons between studies.
We also highlighted that the interest raised by the biomolecular corona would have
been limited without the analytical developments of the recent years. Powerful and sen-
sitive techniques are now available to describe and follow protein corona composition
in vitro. A new challenge is now to follow it in vivo. As culture medium presents a pro-
tein composition different from biological fluids, data on protein coronas in both cases
could perhaps explain why extrapolation from vitro to vivo experiments is so difficult.
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hand, it could reduce toxicity, promote in some cases specific uptake and nuance bio-
distribution, on the other hand it could lead to inflammation processes after activation
of macrophages if misfolded proteins are recognized and screen targeted molecules
grafted on NP surface. Nowadays, one cannot predict the composition of the corona
and its biological consequences: further studies are needed to know how to exploit the
benefits of such corona in vivo. Moreover, now that biomolecular corona prevalence is
well-established, it has to diffuse among a larger scientific community. In particular, it
should be included in theoretical studies and simulations, for example dealing with heat
transfer induced by NP for hyperthermia. Its consequences in imaging should also be
investigated as biomolecular corona might affect fluorescence properties of NP or
fluorescent molecules grafted at their surface.
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